Episode 153: Overviewing the 2025 Alzheimer's Association's Blood-Based Biomarker Guidelines

Episode 153 of the NeurologyLive^® Mind Moments^® podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.

Following the 2025 Alzheimer's Association International Conference (AAIC), Rebecca Edelmayer, PhD, outlines the Alzheimer’s Association’s first clinical practice guidelines for using blood-based biomarkers (BBMs) in the diagnostic workup of suspected Alzheimer’s disease within specialized care. She explains the guideline mission, how tests were evaluated for accuracy, and when BBMs should serve as triage versus confirmatory tools relative to CSF and PET. Edelmayer details current scope limits (cognitively impaired patients in specialty settings), cautions against overextending to primary care or unimpaired populations, and previews the education roll-out—executive summaries, micro-learning modules, and shared decision-making resources. She closes with research priorities: stronger peer-reviewed reporting, broader validation across diverse populations and settings, and building an equitable pathway that leverages BBMs to speed accurate diagnosis and treatment access.

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

• Anti-MTBR Tau Antibody Etalanetug Given FDA Fast Track Designation
• FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
• B-Cell Modulator Obexelimab Shows Pronounced Relapse Reduction in Phase 2 MoonStone Trial

EPISODE BREAKDOWN

• 1:05 – Understanding the purpose and mission behind new blood-based biomarker guidelines
• 2:05 – Key recommendations and defining triage vs confirmatory blood-based biomarker use
• 3:15 – Clinical precautions and where blood-based biomarkers are appropriate today
• 5:30 – Neurology News Minute
• 7:45 – Educating clinicians on implementing BBMs in specialty care
• 10:15 – Research priorities to strengthen evidence and ensure equity

Click here to subscribe to the Mind Moments podcast. Be sure to leave a rating and review for the show. Thanks for listening!

Hoping to listen on your favorite podcast app? See below:

• Click here for Apple Podcasts
• Click here for Spotify
• Click here for Google Podcasts